...
首页> 外文期刊>Danishgah-i Ulum-i Pizishki va Khadamat-i Bihdashti-Darmani Shahid Sadugi Yazd. Majallah >Molecular Detection and Identification of Α-L-Iduronidase Gene Mutations in 5 Iranian Families Suspected for Muller Syndrome (Mucopolysaccharidosis I)
【24h】

Molecular Detection and Identification of Α-L-Iduronidase Gene Mutations in 5 Iranian Families Suspected for Muller Syndrome (Mucopolysaccharidosis I)

机译:五个穆勒氏综合症(Mucopolysaccharidosis I)的伊朗家庭的α-L-杜鹃酸酶基因突变的分子检测和鉴定。

获取原文

摘要

Introduction: Mucopolysaccharidosis I (MPS-I) is an autosomal recessive lysosomal storage diseases, caused by α-L-iduronidase (IDUA) enzyme deficiency. The clinical manifestations of MPS-I patients are variable ranging from severe to mild, and therefore prediction of disease severity is difficult. From when IDUA gene has been cloned more than 109 distinct mutations have been identified in it and this number is increasing. This mutation analysis has provided some molecular explanations for the range of MPS-I phenotypes. The aim of this study was identification and molecular characterization of IDUA gene mutations in our subset of MPS I patients.Methods: The present study performed on 5 Iranian families, each with a suspected child for MPS-I. Initially by using enzyme activity assay, the Hurler syndrome was verified and then presence of L123R mutation was evaluated by PCR-SSCP. Finally by PCR amplification of all 14 exons of the gene, SSCP and sequencing the mutations underlying the disease were identified and characterized.Results: The detected mutations turned to be L123R (in 2 patients), W402X, P533R and G51D mutations in other 3 patients.Discussion: L123R mutation, which was reported for the first time from our centre, was also present in 2 of the patients of this study but other 3 mutations were not novel. From our results, as well others, it can be concluded that the range of mutations in IDUA gene differ in different geographical areas. This should be considered when designing mutation detection strategies for MPS-I.
机译:简介:粘多糖贮积病I(MPS-I)是一种常染色体隐性溶酶体贮积病,由α-L-艾杜糖醛酸酶(IDUA)酶缺乏引起。 MPS-1患者的临床表现从严重到轻度不等,因此很难预测疾病的严重程度。自从克隆IDUA基因以来,已经鉴定出109个以上的独特突变,并且该数目正在增加。该突变分析为MPS-1表型的范围提供了一些分子解释。这项研究的目的是在我们的MPS I患者亚组中鉴定IDUA基因突变并对其进行分子表征。方法:本研究针对5个伊朗家庭进行,每个家庭都有一个疑似MPS-I的孩子。最初通过酶活性测定,验证了Hurler综合征,然后通过PCR-SSCP评估了L123R突变的存在。最后,通过PCR扩增该基因的所有14个外显子,鉴定并表征了该疾病的潜在突变。结果:检测到的突变为2例患者的L123R,3例W402X,P533R和G51D突变讨论:本研究中心首次报道了L123R突变,该研究的2位患者中也存在L123R突变,但其他3个突变并非新颖。从我们的结果以及其他结果可以得出结论,IDUA基因的突变范围在不同的地理区域是不同的。在设计MPS-1的突变检测策略时应考虑到这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号